Last update 21 Nov 2024

VPI-2690B

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Target
αvβ3
Mechanism
αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists)
Therapeutic Areas
Endocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication
Diabetic Nephropathies
Inactive Indication-
Originator Organization
The University of North Carolina at Chapel HillThe University of North Carolina at Chapel Hill
Active Organization
The University of North Carolina at Chapel HillThe University of North Carolina at Chapel Hill
Inactive Organization
Vascular Pharmaceuticals, Inc.Vascular Pharmaceuticals, Inc.
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VPI-2690B
NCT02251067 / CompletedPhase 2
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
100 Clinical Results associated with VPI-2690B
Login to view more data
100 Translational Medicine associated with VPI-2690B
Login to view more data
100 Patents (Medical) associated with VPI-2690B
Login to view more data
100 Deals associated with VPI-2690B
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic NephropathiesPhase 2-
The University of North Carolina at Chapel HillThe University of North Carolina at Chapel Hill
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free